Clozapine for self-injurious behavior in individuals with borderline personality disorder
- Theodore Zarzar,
- Central Regional Hospital
Scholary Output:
Contribution to journal
Article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Prior reports suggest that clozapine can markedly reduce aggression and self-injurious behavior in patients with borderline personality disorder (BPD). We present a series of four patients with BPD and persistent self-injurious behavior treated with clozapine at a state psychiatric hospital. After treatment with clozapine these patients ceased self-injurious behaviors and aggression, and no longer required intensive levels of observation or restrictive procedures. All were successfully discharged from the hospital soon after initiation of clozapine. Clozapine appears to be efficacious in the management of chronic suicidality, self-injurious behaviors and aggression in patients with severe BPD.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 272-274 (3 pages)Journal (Volume, Issue Number)
Therapeutic Advances in Psychopharmacology (Volume 3, Issue 5)Publication milestones
- Published - 10/2013
Publication status
Published - 10/2013
ISSN
2045-1253Publication IDs
- Scopus: 84998153458
Publication metrics
Metrics
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
SciVal
FWCI
1.54
SciVal
Author count
2
SciVal
citations
10
SciVal
Paper percentile
66
PlumX, opens in new tab
Captures
57
Citation count
19
Funding Details
T.Z. reports no conflict of interest. J.M. has received grant support from Merck, Roche/Genentech and PsychoGenics, and speakers’ fees from Eli Lilly and Sunovion.
FundersFunding numbers
Genentech
-Merck
-